InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Mann Paul Elliot, Director. Officer active across 3 companies, notably Abeona Therapeutics INC.. In total, 8 disclosures have been logged. Activity tracked since 25 May 2021. The latest transaction was filed on 30 December 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
8 of 8 declarations
Mann Paul Elliot is a Board Member at ABEONA THERAPEUTICS INC. As a board member, he contributes to the governance of the company and the formulation of strategies for its development in the field of gene therapies.